Prolyl hydroxylase-3 is a novel renal cell carcinoma biomarker

PURPOSE: The aim of this study was to determine the suitability of serum prolyl hydroxylase-3 (PHD3) as a diagnostic or monitoring biomarker of renal cell carcinoma (RCC). MATERIALS AND METHODS: Between October 2013 and March 2015, we prospectively recruited study participants. The RCC group consist...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Kwang Hyun, Lee, Hyung Ho, Yoon, Young Eun, Na, Joon Chae, Kim, Kyung Sup, Han, Woong Kyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Urological Association 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6821991/
https://www.ncbi.nlm.nih.gov/pubmed/31692952
http://dx.doi.org/10.4111/icu.2019.60.6.425

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6821991/
https://www.ncbi.nlm.nih.gov/pubmed/31692952
http://dx.doi.org/10.4111/icu.2019.60.6.425

Ejemplares similares